HEADER TRANSCRIPTION 16-NOV-15 5FNU TITLE STRUCTURE OF THE KEAP1 KELCH DOMAIN IN COMPLEX WITH A SMALL MOLECULE TITLE 2 INHIBITOR. COMPND MOL_ID: 1; COMPND 2 MOLECULE: KELCH-LIKE ECH-ASSOCIATED PROTEIN 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KELCH DOMAIN, UNP RESIDUES 322-624; COMPND 5 SYNONYM: CYTOSOLIC INHIBITOR OF NRF2, INRF2, KEAP1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSCRIPTION, KEAP1, NRF2, OXIDATIVE STRESS EXPDTA X-RAY DIFFRACTION AUTHOR T.G.DAVIES,W.E.WIXTED,J.E.COYLE,C.GRIFFITHS-JONES,K.HEARN, AUTHOR 2 R.MCMENAMIN,D.NORTON,S.J.RICH,C.RICHARDSON,G.SAXTY,H.M.G.WILLEMS, AUTHOR 3 A.J.WOOLFORD,J.E.COTTOM,J.KOU,J.G.YONCHUK,H.G.FELDSER,Y.SANCHEZ, AUTHOR 4 J.P.FOLEY,B.J.BOLOGNESE,G.LOGAN,P.L.PODOLIN,H.YAN,J.F.CALLAHAN, AUTHOR 5 T.D.HEIGHTMAN,J.K.KERNS REVDAT 4 10-JAN-24 5FNU 1 REMARK REVDAT 3 04-APR-18 5FNU 1 REMARK ATOM REVDAT 2 11-MAY-16 5FNU 1 JRNL REVDAT 1 13-APR-16 5FNU 0 JRNL AUTH T.G.DAVIES,W.E.WIXTED,J.E.COYLE,C.GRIFFITHS-JONES,K.HEARN, JRNL AUTH 2 R.L.MCMENAMIN,D.NORTON,S.J.RICH,C.RICHARDSON,G.SAXTY, JRNL AUTH 3 H.M.G.WILLEMS,A.J.WOOLFORD,J.E.COTTOM,J.KOU,J.G.YONCHUK, JRNL AUTH 4 H.G.FELDSER,Y.SANCHEZ,J.P.FOLEY,B.J.BOLOGNESE,G.A.LOGAN, JRNL AUTH 5 P.L.PODOLIN,H.YAN,J.F.CALLAHAN,T.D.HEIGHTMAN,J.K.KERNS JRNL TITL MONO-ACIDIC INHIBITORS OF THE KELCH-LIKE ECH-ASSOCIATED JRNL TITL 2 PROTEIN 1 : NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2 JRNL TITL 3 (KEAP1:NRF2) PROTEIN-PROTEIN INTERACTION WITH HIGH CELL JRNL TITL 4 POTENCY IDENTIFIED BY FRAGMENT-BASED DISCOVERY. JRNL REF J.MED.CHEM. V. 59 3991 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 27031670 JRNL DOI 10.1021/ACS.JMEDCHEM.6B00228 REMARK 2 REMARK 2 RESOLUTION. 1.78 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0107 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.78 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 51.65 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 87.5 REMARK 3 NUMBER OF REFLECTIONS : 27225 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.168 REMARK 3 R VALUE (WORKING SET) : 0.166 REMARK 3 FREE R VALUE : 0.205 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1473 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.78 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.83 REMARK 3 REFLECTION IN BIN (WORKING SET) : 958 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 42.22 REMARK 3 BIN R VALUE (WORKING SET) : 0.2420 REMARK 3 BIN FREE R VALUE SET COUNT : 59 REMARK 3 BIN FREE R VALUE : 0.2930 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2215 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 363 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.56 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.09000 REMARK 3 B22 (A**2) : -0.09000 REMARK 3 B33 (A**2) : 0.30000 REMARK 3 B12 (A**2) : -0.05000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.125 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.121 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.078 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.751 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.940 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2328 ; 0.011 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 29 ; 0.002 ; 0.022 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3179 ; 1.439 ; 1.929 REMARK 3 BOND ANGLES OTHERS (DEGREES): 63 ; 0.170 ; 0.925 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 293 ; 7.164 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 112 ;32.850 ;22.625 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 344 ;14.072 ;15.087 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;16.767 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 333 ; 0.101 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1838 ; 0.001 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 9 ; 0.000 ; 0.015 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1157 ; 0.781 ; 1.816 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1171 ; 1.803 ; 2.313 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 326 A 613 REMARK 3 ORIGIN FOR THE GROUP (A): 22.6715 61.4949 37.8561 REMARK 3 T TENSOR REMARK 3 T11: 0.0267 T22: 0.0078 REMARK 3 T33: 0.0416 T12: 0.0058 REMARK 3 T13: -0.0164 T23: 0.0040 REMARK 3 L TENSOR REMARK 3 L11: 2.1634 L22: 2.4159 REMARK 3 L33: 1.0686 L12: -0.1157 REMARK 3 L13: -0.6183 L23: 0.4380 REMARK 3 S TENSOR REMARK 3 S11: -0.0431 S12: -0.0456 S13: -0.0534 REMARK 3 S21: 0.1536 S22: 0.0314 S23: 0.0773 REMARK 3 S31: 0.0361 S32: 0.0354 S33: 0.0117 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 5FNU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-NOV-15. REMARK 100 THE DEPOSITION ID IS D_1290065546. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-APR-13 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54187 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28698 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.780 REMARK 200 RESOLUTION RANGE LOW (A) : 51.650 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.5 REMARK 200 DATA REDUNDANCY : 2.200 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.78 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.84 REMARK 200 COMPLETENESS FOR SHELL (%) : 44.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.19000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 1X2J REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.79 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.61 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.3-0.6 (NH4)2SO4, 0.4-1.4 M LI2SO4 REMARK 280 AND 0.1 M NA3CITRATE-HCL PH 5.6, PH 7 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 18.81133 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 37.62267 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 28.21700 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 47.02833 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 9.40567 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 321 REMARK 465 PRO A 322 REMARK 465 LYS A 323 REMARK 465 VAL A 324 REMARK 465 GLY A 325 REMARK 465 ARG A 614 REMARK 465 LYS A 615 REMARK 465 GLN A 616 REMARK 465 ILE A 617 REMARK 465 ASP A 618 REMARK 465 GLN A 619 REMARK 465 GLN A 620 REMARK 465 ASN A 621 REMARK 465 CYS A 622 REMARK 465 THR A 623 REMARK 465 CYS A 624 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 336 -41.25 69.10 REMARK 500 THR A 481 -50.11 -124.47 REMARK 500 HIS A 516 -120.51 56.54 REMARK 500 GLN A 528 -50.23 -122.53 REMARK 500 VAL A 547 -168.97 -111.75 REMARK 500 HIS A 575 -48.31 -143.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2167 DISTANCE = 6.25 ANGSTROMS REMARK 525 HOH A2177 DISTANCE = 6.29 ANGSTROMS REMARK 525 HOH A2194 DISTANCE = 6.75 ANGSTROMS REMARK 525 HOH A2197 DISTANCE = 6.43 ANGSTROMS REMARK 525 HOH A2213 DISTANCE = 6.22 ANGSTROMS REMARK 525 HOH A2227 DISTANCE = 6.85 ANGSTROMS REMARK 525 HOH A2239 DISTANCE = 7.03 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L6I A 1615 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1616 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5FNQ RELATED DB: PDB REMARK 900 STRUCTURE OF THE KEAP1 KELCH DOMAIN IN COMPLEX WITH A SMALL REMARK 900 MOLECULE INHIBITOR. REMARK 900 RELATED ID: 5FNR RELATED DB: PDB REMARK 900 STRUCTURE OF THE KEAP1 KELCH DOMAIN IN COMPLEX WITH A SMALL REMARK 900 MOLECULE INHIBITOR. REMARK 900 RELATED ID: 5FNS RELATED DB: PDB REMARK 900 STRUCTURE OF THE KEAP1 KELCH DOMAIN IN COMPLEX WITH A SMALL REMARK 900 MOLECULE INHIBITOR. REMARK 900 RELATED ID: 5FNT RELATED DB: PDB REMARK 900 STRUCTURE OF THE KEAP1 KELCH DOMAIN IN COMPLEX WITH A SMALL REMARK 900 MOLECULE INHIBITOR. DBREF 5FNU A 322 624 UNP Q9Z2X8 KEAP1_MOUSE 322 624 SEQADV 5FNU GLY A 321 UNP Q9Z2X8 EXPRESSION TAG SEQRES 1 A 304 GLY PRO LYS VAL GLY ARG LEU ILE TYR THR ALA GLY GLY SEQRES 2 A 304 TYR PHE ARG GLN SER LEU SER TYR LEU GLU ALA TYR ASN SEQRES 3 A 304 PRO SER ASN GLY SER TRP LEU ARG LEU ALA ASP LEU GLN SEQRES 4 A 304 VAL PRO ARG SER GLY LEU ALA GLY CYS VAL VAL GLY GLY SEQRES 5 A 304 LEU LEU TYR ALA VAL GLY GLY ARG ASN ASN SER PRO ASP SEQRES 6 A 304 GLY ASN THR ASP SER SER ALA LEU ASP CYS TYR ASN PRO SEQRES 7 A 304 MET THR ASN GLN TRP SER PRO CYS ALA SER MET SER VAL SEQRES 8 A 304 PRO ARG ASN ARG ILE GLY VAL GLY VAL ILE ASP GLY HIS SEQRES 9 A 304 ILE TYR ALA VAL GLY GLY SER HIS GLY CYS ILE HIS HIS SEQRES 10 A 304 SER SER VAL GLU ARG TYR GLU PRO GLU ARG ASP GLU TRP SEQRES 11 A 304 HIS LEU VAL ALA PRO MET LEU THR ARG ARG ILE GLY VAL SEQRES 12 A 304 GLY VAL ALA VAL LEU ASN ARG LEU LEU TYR ALA VAL GLY SEQRES 13 A 304 GLY PHE ASP GLY THR ASN ARG LEU ASN SER ALA GLU CYS SEQRES 14 A 304 TYR TYR PRO GLU ARG ASN GLU TRP ARG MET ILE THR PRO SEQRES 15 A 304 MET ASN THR ILE ARG SER GLY ALA GLY VAL CYS VAL LEU SEQRES 16 A 304 HIS ASN CYS ILE TYR ALA ALA GLY GLY TYR ASP GLY GLN SEQRES 17 A 304 ASP GLN LEU ASN SER VAL GLU ARG TYR ASP VAL GLU THR SEQRES 18 A 304 GLU THR TRP THR PHE VAL ALA PRO MET ARG HIS HIS ARG SEQRES 19 A 304 SER ALA LEU GLY ILE THR VAL HIS GLN GLY LYS ILE TYR SEQRES 20 A 304 VAL LEU GLY GLY TYR ASP GLY HIS THR PHE LEU ASP SER SEQRES 21 A 304 VAL GLU CYS TYR ASP PRO ASP SER ASP THR TRP SER GLU SEQRES 22 A 304 VAL THR ARG MET THR SER GLY ARG SER GLY VAL GLY VAL SEQRES 23 A 304 ALA VAL THR MET GLU PRO CYS ARG LYS GLN ILE ASP GLN SEQRES 24 A 304 GLN ASN CYS THR CYS HET L6I A1615 68 HET CL A1616 1 HETNAM L6I (3S)-3-(7-METHOXY-1-METHYL-1H-BENZO[D][1,2,3]TRIAZOL-5- HETNAM 2 L6I YL)-3-(4-METHYL-3-(((R)-4-METHYL-1,1-DIOXIDO-3,4- HETNAM 3 L6I DIHYDRO-2H-BENZO[B][1,4,5]OXATHIAZEPIN-2-YL)METHYL) HETNAM 4 L6I PHENYL)PROPANOIC ACID HETNAM CL CHLORIDE ION FORMUL 2 L6I C28 H30 N4 O6 S FORMUL 3 CL CL 1- FORMUL 4 HOH *363(H2 O) HELIX 1 1 PRO A 492 ASN A 495 5 4 SHEET 1 AA 4 TRP A 352 ARG A 354 0 SHEET 2 AA 4 LEU A 342 TYR A 345 -1 O ALA A 344 N LEU A 353 SHEET 3 AA 4 LEU A 327 ALA A 331 -1 O ILE A 328 N TYR A 345 SHEET 4 AA 4 GLY A 605 THR A 609 -1 O GLY A 605 N ALA A 331 SHEET 1 AB 4 ALA A 366 VAL A 370 0 SHEET 2 AB 4 LEU A 373 VAL A 377 -1 O LEU A 373 N VAL A 370 SHEET 3 AB 4 LEU A 393 TYR A 396 -1 O ASP A 394 N ALA A 376 SHEET 4 AB 4 TRP A 403 PRO A 405 -1 O SER A 404 N CYS A 395 SHEET 1 AC 2 ARG A 380 SER A 383 0 SHEET 2 AC 2 GLY A 386 ASP A 389 -1 O GLY A 386 N SER A 383 SHEET 1 AD 4 GLY A 417 ILE A 421 0 SHEET 2 AD 4 HIS A 424 VAL A 428 -1 O HIS A 424 N ILE A 421 SHEET 3 AD 4 VAL A 440 TYR A 443 -1 O GLU A 441 N ALA A 427 SHEET 4 AD 4 TRP A 450 VAL A 453 -1 O HIS A 451 N ARG A 442 SHEET 1 AE 2 SER A 431 HIS A 432 0 SHEET 2 AE 2 ILE A 435 HIS A 436 -1 O ILE A 435 N HIS A 432 SHEET 1 AF 4 GLY A 464 LEU A 468 0 SHEET 2 AF 4 LEU A 471 VAL A 475 -1 O LEU A 471 N LEU A 468 SHEET 3 AF 4 ALA A 487 TYR A 491 -1 O GLU A 488 N ALA A 474 SHEET 4 AF 4 GLU A 496 ILE A 500 -1 O GLU A 496 N TYR A 491 SHEET 1 AG 4 GLY A 511 LEU A 515 0 SHEET 2 AG 4 CYS A 518 ALA A 522 -1 O CYS A 518 N LEU A 515 SHEET 3 AG 4 VAL A 534 ASP A 538 -1 O GLU A 535 N ALA A 521 SHEET 4 AG 4 THR A 543 VAL A 547 -1 O THR A 543 N ASP A 538 SHEET 1 AH 4 GLY A 558 HIS A 562 0 SHEET 2 AH 4 LYS A 565 LEU A 569 -1 O LYS A 565 N HIS A 562 SHEET 3 AH 4 SER A 580 ASP A 585 -1 O GLU A 582 N VAL A 568 SHEET 4 AH 4 THR A 590 ARG A 596 -1 O THR A 590 N ASP A 585 SITE 1 AC1 17 TYR A 334 SER A 363 GLY A 364 ASN A 382 SITE 2 AC1 17 ARG A 415 PHE A 478 ARG A 483 SER A 508 SITE 3 AC1 17 GLY A 509 TYR A 525 GLN A 530 SER A 555 SITE 4 AC1 17 ALA A 556 TYR A 572 SER A 602 GLY A 603 SITE 5 AC1 17 HOH A2095 SITE 1 AC2 3 ASN A 414 HOH A2048 HOH A2061 CRYST1 103.297 103.297 56.434 90.00 90.00 120.00 P 61 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009681 0.005589 0.000000 0.00000 SCALE2 0.000000 0.011178 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017720 0.00000